Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niraparib and Sintilimab in Recurrent/Metastatic Nasopharyngeal Carcinoma
NCT05162872Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2021
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of niraparib in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
niraparib
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT05162872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05162872.